Daniel Appelbaum

NPI: 1184775157
Total Payments
$160,532
2024 Payments
$104,193
Companies
4
Transactions
107
Medicare Patients
2,595
Medicare Billing
$192,625

Payment Breakdown by Category

Other$138,850 (86.5%)
Consulting$9,706 (6.0%)
Travel$9,350 (5.8%)
Food & Beverage$2,626 (1.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $138,850 37 86.5%
Consulting Fee $9,706 5 6.0%
Travel and Lodging $9,350 29 5.8%
Food and Beverage $2,626 36 1.6%

Top Paying Companies

Company Total Records Latest Year
PROGENICS PHARMACEUTICALS, INC. $151,095 99 $0 (2024)
Novartis Pharmaceuticals Corporation $5,308 5 $0 (2024)
Blue Earth Diagnostics Limited $4,100 2 $0 (2022)
AbbVie Inc. $29.47 1 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $104,193 65 PROGENICS PHARMACEUTICALS, INC. ($102,444)
2023 $46,278 34 Progenics Pharmaceuticals, Inc. ($42,720)
2022 $8,682 5 Progenics Pharmaceuticals, Inc. ($5,482)
2021 $29.47 1 AbbVie Inc. ($29.47)
2020 $450.00 1 Progenics Pharmaceuticals, Inc. ($450.00)
2019 $900.00 1 Blue Earth Diagnostics Limited ($900.00)

All Payment Transactions

107 individual payment records from CMS Open Payments — Page 1 of 5

Date Company Product Nature Form Amount Type
12/18/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,770.00 General
Category: RADIOPHARMACEUTICAL
12/18/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $268.34 General
Category: RADIOPHARMACEUTICAL
12/18/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $121.15 General
Category: RADIOPHARMACEUTICAL
12/10/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,155.00 General
Category: RADIOPHARMACEUTICAL
12/10/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $542.76 General
Category: RADIOPHARMACEUTICAL
12/10/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $105.30 General
Category: RADIOPHARMACEUTICAL
12/04/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,155.00 General
Category: RADIOPHARMACEUTICAL
12/04/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $467.86 General
Category: RADIOPHARMACEUTICAL
12/04/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $87.09 General
Category: RADIOPHARMACEUTICAL
11/20/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $4,770.00 General
Category: RADIOPHARMACEUTICAL
11/20/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $150.76 General
Category: RADIOPHARMACEUTICAL
11/20/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $119.29 General
Category: RADIOPHARMACEUTICAL
11/12/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,155.00 General
Category: RADIOPHARMACEUTICAL
11/12/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $364.12 General
Category: RADIOPHARMACEUTICAL
11/12/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $51.73 General
Category: RADIOPHARMACEUTICAL
10/29/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $3,180.00 General
Category: RADIOPHARMACEUTICAL
10/29/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $124.45 General
Category: RADIOPHARMACEUTICAL
10/29/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $43.20 General
Category: RADIOPHARMACEUTICAL
10/22/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,155.00 General
Category: RADIOPHARMACEUTICAL
10/22/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $549.48 General
Category: RADIOPHARMACEUTICAL
10/22/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $57.68 General
Category: RADIOPHARMACEUTICAL
10/22/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $21.00 General
Category: RADIOPHARMACEUTICAL
10/21/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $7,155.00 General
Category: RADIOPHARMACEUTICAL
10/21/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Travel and Lodging In-kind items and services $514.18 General
Category: RADIOPHARMACEUTICAL
10/21/2024 PROGENICS PHARMACEUTICALS, INC. PYLARIFY (Drug) Food and Beverage In-kind items and services $106.50 General
Category: RADIOPHARMACEUTICAL

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 8 412 435 $302,185 $30,263
2022 10 627 682 $444,866 $48,030
2021 13 772 851 $513,201 $60,097
2020 14 784 876 $431,619 $54,236
Total Patients
2,595
Total Services
2,844
Medicare Billing
$192,625
Procedure Codes
45

All Medicare Procedures & Services

45 procedure records from CMS Medicare Utilization — Page 1 of 2

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Facility 2023 204 224 $195,162 $19,614 10.1%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Facility 2023 100 100 $57,265 $5,572 9.7%
78816 Nuclear medicine study whole body with ct scan Facility 2023 16 17 $14,964 $1,532 10.2%
78306 Nuclear medicine study of bone and/or joint whole body Facility 2023 42 44 $13,759 $1,401 10.2%
78072 Nuclear medicine study of parathyroid with spect and ct scan Facility 2023 11 11 $6,152 $613.90 10.0%
78451 Nuclear medicine study of heart muscle at rest and with stress and spect Facility 2023 11 11 $5,358 $584.87 10.9%
78803 Nuclear medicine study, spect imaging, 1 area or single acquisition, single day imaging Facility 2023 14 14 $5,299 $544.18 10.3%
78598 Nuclear medicine study of lung ventilation and circulation and blood flow to lung Facility 2023 14 14 $4,226 $400.13 9.5%
78815 Nuclear medicine study from skull base to mid-thigh with ct scan Facility 2022 280 311 $260,365 $28,063 10.8%
78452 Nuclear medicine studies of heart muscle at rest and with stress and spect Facility 2022 125 125 $69,129 $7,672 11.1%
79101 Radioactive drug therapy through a vein Facility 2022 29 43 $28,477 $2,991 10.5%
78816 Nuclear medicine study whole body with ct scan Facility 2022 23 28 $23,809 $2,523 10.6%
78306 Nuclear medicine study of bone and/or joint whole body Facility 2022 56 60 $17,928 $1,878 10.5%
78803 Nuclear medicine study, 1 area with spect Facility 2022 39 39 $14,183 $1,564 11.0%
78608 Nuclear medicine study of brain with metabolic evaluation Facility 2022 22 22 $11,192 $1,225 10.9%
78195 Nuclear medicine study of lymphatic system Facility 2022 23 24 $10,016 $1,019 10.2%
78582 Nuclear medicine study of lung ventilation and circulation Facility 2022 18 18 $6,669 $741.35 11.1%
78264 Nuclear medicine study of stomach to assess emptying Facility 2022 12 12 $3,098 $353.81 11.4%
78815 Nuclear medicine study with ct imaging skull base to mid-thigh Facility 2021 306 344 $279,304 $32,807 11.7%
78452 Nuclear medicine study of vessels of heart using drugs or exercise multiple studies Facility 2021 130 130 $69,141 $8,140 11.8%
78816 Nuclear medicine study with ct imaging whole body Facility 2021 37 44 $36,196 $4,276 11.8%
78306 Bone and/or joint imaging, whole body Facility 2021 93 114 $33,073 $3,758 11.4%
79101 Radioactive material therapy into vein, not radiolabeled Facility 2021 25 37 $23,935 $3,005 12.6%
78803 Spect nuclear medicine localization of tumor or inflammation or study of distribution of radioactive tracer in single area, 1 day of imaging Facility 2021 41 41 $14,425 $1,486 10.3%
78608 Nuclear medicine study brain with metabolic evaluation Facility 2021 26 26 $12,725 $1,428 11.2%

About Daniel Appelbaum

Daniel Appelbaum is a Nuclear Radiology healthcare provider based in Chicago, Illinois. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/16/2007. The National Provider Identifier (NPI) number assigned to this provider is 1184775157.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Daniel Appelbaum has received a total of $160,532 in payments from pharmaceutical and medical device companies, with $104,193 received in 2024. These payments were reported across 107 transactions from 4 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($138,850).

As a Medicare-enrolled provider, Appelbaum has provided services to 2,595 Medicare beneficiaries, totaling 2,844 services with total Medicare billing of $192,625. Data is available for 4 years (2020–2023), covering 45 distinct procedure/service records.

Practice Information

  • Specialty Nuclear Radiology
  • Location Chicago, IL
  • Active Since 01/16/2007
  • Last Updated 10/24/2022
  • Taxonomy Code 2085N0904X
  • Entity Type Individual
  • NPI Number 1184775157

Products in Payments

  • PYLARIFY (Drug) $150,645
  • Axumin (Drug) $4,100
  • LUTATHERA (Drug) $1,839
  • PLUVICTO (Drug) $30.87
  • UBRELVY (Drug) $29.47

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Nuclear Radiology Doctors in Chicago